Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Current and Projected Market Size of the Controlled Release Drug Delivery Industry?
The market for controlled release drug delivery has experienced rapid expansion in recent times. The market which was worth $65.44 billion in 2024 is projected to escalate to $72.34 billion in 2025, with a compound annual growth rate (CAGR) of 10.5%. Factors contributing to this growth during the historic period include advancements in drug delivery systems, the development of early polymer-based formulations, the introduction of microencapsulation methods, the rise of transdermal delivery, regular approvals from authorities, and increasing standardization.
Over the following years, a swift expansion is anticipated in the controlled release drug delivery market’s size, projected to reach “$117.24 billion in 2029, with a compound annual growth rate (CAGR) of 12.8%. The upcoming growth can be linked to the shift towards personalized medicine, the incorporation of technology for patient convenience, the proliferation of biologics and biosimilars, market spread in developing regions, and advances in polymer science. The major anticipated trends in this growth period involve biodegradable and biocompatible materials, progress in nanotechnology, individualized medicine and targeted therapies, improvements in implantable devices, and groundbreaking encapsulation techniques.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9930&type=smp
#Which Factors Are Currently Driving The Growth Of The Controlled Release Drug Delivery Market?
The escalating occurrence of enduring ailments is anticipated to push the expansion of the controlled release drug delivery market. Noncommunicable or chronic diseases include conditions such as cancer, diabetes, and heart disease, which can continue for more than a year and often necessitate ongoing medical treatment while inhibiting day-to-day tasks. Controlled-release drug delivery proves crucial for managing chronic conditions. For individuals dealing with prolonged illnesses or those living in areas with restricted healthcare resources, drug delivery methods facilitating extended medicinal release are vital. For example, a September 2022 report by the World Health Organization (WHO), a Swiss institutional expert in health, revealed that annually, chronic diseases claim 41 million lives, accounting for 74 percent of global deaths. Before reaching the age of 70, 17 million people succumb to chronic diseases, and approximately 77 percent of chronic disease-related deaths occur in economically less abundant countries. These figures are predicted to increase in the future, thus the escalating incidence of chronic diseases is fueling the expansion of the controlled release drug delivery market.
How Is The Global Controlled Release Drug Delivery Market Structured In Terms Of Segments?
The controlled release drug delivery market covered in this report is segmented –
1) By Technology: Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Other Technologies
2) By Release Mechanism: Polymer Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-Modulated Drug Delivery Systems, Chemically Activated,
3) By Application: Metered Dose Inhalers, Injectable, Transdermal And Ocular Patches, Other Applications
4) By End User: Hospitals, Clinics, Personal, Research, Other End Users
Subsegments:
1) By Wurster Technique: Spray Coating, Fluid Bed Coating
2) By Coacervation: Simple Coacervation, Complex Coacervation
3) By Micro Encapsulation: Polymer-Based Micro Encapsulation, Lipid-Based Micro Encapsulation
4) By Implants: Biodegradable Implants, Non-Biodegradable Implants
5) By Transdermal: Microneedle Patches, Reservoir Systems, Matrix Systems
6) By Targeted Delivery: Nanoparticles, Antibody-Drug Conjugates, Liposomes
7) By Other Technologies: Osmotic Pumps, In Situ Gelling Systems
What Notable Trends Are Shaping The Direction Of The Controlled Release Drug Delivery Market?
The proliferation of technological improvement is increasingly becoming a prominent trend within the controlled-release drug delivery market. Major players in this space are leveraging new innovations in technology to maintain market dominance. For example, in March 2022, Germany’s Evonik Industries AG introduced UDRATEC SoluFlow to the market, a cutting-edge microparticle technology crafted to enhance the solubility of active pharmaceutical ingredients within oral medicinal formulas. This innovative technique surpasses the solubility limitations of conventional production techniques. The addition of UDRATEC SoluFlow to Evonik Health Care’s suite of offerings, which encompass oral excipients such as EUDRAGIT Funcional polymers, and also a unique ready-to-load capsules like EUDRACAPTM, along with other offerings, highlights the company’s commitment to boost medication performance.
Who Are The Main Participants Shaping The Controlled Release Drug Delivery Market Landscape?
Major companies operating in the controlled release drug delivery market include Johnson & Johnson Services Inc., Merck & Co. Inc., Alkermes plc, Coating Place Inc., Corium International Inc., Depomed Inc., Pfizer Inc., Aradigm Corporation, Capsugel LLC, GlaxoSmithKline plc, Bayer Healthcare LLC, Collegium Pharmaceuticals Inc., GE HealthCare Technologies Inc., Adare Pharmaceuticals Inc., Allergan plc, Novartis AG, Lonza Group AG, Colorcon Inc., SKY Pharmaceuticals Pvt. Ltd., AstraZeneca plc, Biogen Inc., Orbis Biosciences Inc., Alza Corporation, MicroCHIPS Inc., Endo International plc, Heron Therapeutics Inc., Intellipharmaceutics International Inc., Ipsen Biopharmaceuticals Inc., Luye Pharma Group Ltd., Medtronic plc, Nektar Therapeutics, Novo Nordisk A/S, Ocular Therapeutix Inc., Pacira BioSciences Inc., Progenity Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Titan Pharmaceuticals Inc., Vectura Group plc, West Pharmaceutical Services Inc., Zosano Pharma Corporation, Zynerba Pharmaceuticals Inc.
Get The Full Report Here:
Which Region Currently Holds The Largest Share In The Controlled Release Drug Delivery Market?
North America was the largest region in the controlled release drug delivery market in 2024. The regions covered in the controlled release drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=9930&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model